Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Guelph

$50,138.00

Engineered hypo-allergens for specific immunotherapy for food allergy

FY 2008-09

Summary
Food allergy is a major health concern in both children and adults. Food-hypersensitivity reactions affect about 8% of children and 3 % of adults. Hen egg white is one of the most common sources of allergic reactions, mainly in children. Approximately, two-thirds of children diagnosed with food allergies are reactive to egg white. Our previous work has been clearly identified ovalbumin (OA) and ovomucoid (OVM) as major egg white allergens. Furthermore, we have completed detailed B-cell and T-cell epitope mapping of both allergens and identified critical amino acids that affect IgE binding activity. This information will enable us to design specific hypo-allergens for immunotherapy. The hypothesis is that specifically designed recombinant OA and OVM allergens or peptides that lack of IgE-epitopes (low allergenicity), but show good T-cell antigenecity (retain T-cell epitopes) could induce tolerance to egg allergens which represent an attractive solution to prevent and treat egg allergy. This could result in specific T-cell tolerance or anergy against the antigens. Modification of allergens will be performed by two different approaches, 1) recombinant hybrid peptides comprising OA or OVM MHC class II-restricted T-cell epitopes with E. coli expression system, and 2) site-directed mutagenesis altering dominant B-cell epitope structure or tertiary structure of the proteins. Hypo-sensitization and therapeutic tolerance of egg allergy will be evaluated using experimentally-induced allergy mice (BALB/c) by means of intraperitoneal of antigens. Analysis of Th1/Th2 and T-regulatory cells-associated cytokines (IFN-gamma, IL-4, IL-10, IL-12 and TGF-beta), specific antibodies (IgE, IgG1, IgG2a and IgG4) and histamine levels will be analyzed by enzyme-linked immunosorbent assay (ELISA) (splenocytes and sera) or real-time RT-PCR technique (mucosal immunity). The significance of the proposed project are 1) to direct us to develop hypo-food allergens or peptide-based immunotherapy for food allergic diseases, 2) better understanding mechanism of recombinant hypoallergen-induced immunotorelance, 3) to facilitate training of highly qualified personnel in food biotechnology/immunology/food safety area.
Program
Discovery Grants Program - Individual
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
184794-2006
Name nom
Mine, Yoshinori
Department département
Food Science
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2008
Competition year année de concours
2006
Award amount
50138
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1011
Committee name en
Integrative Animal Biology
Committee name fr
Biologie Animale Intégrative
Area of application code
100
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Agriculture and primary food production
Area of application fr
Agriculture et produits alimentaires primaires
Research subject code
6100
Research subject group en
Food science and technology
Research subject group fr
Science et technologie de l'alimentation
Research subject en
Food science and technology
Research subject fr
Science et technologie de l'alimentation
Partie
3
Nb partie
5
Application title
Engineered hypo-allergens for specific immunotherapy for food allergy
Keyword
NA
Application summary
Food allergy is a major health concern in both children and adults. Food-hypersensitivity reactions affect about 8% of children and 3 % of adults. Hen egg white is one of the most common sources of allergic reactions, mainly in children. Approximately, two-thirds of children diagnosed with food allergies are reactive to egg white. Our previous work has been clearly identified ovalbumin (OA) and ovomucoid (OVM) as major egg white allergens. Furthermore, we have completed detailed B-cell and T-cell epitope mapping of both allergens and identified critical amino acids that affect IgE binding activity. This information will enable us to design specific hypo-allergens for immunotherapy. The hypothesis is that specifically designed recombinant OA and OVM allergens or peptides that lack of IgE-epitopes (low allergenicity), but show good T-cell antigenecity (retain T-cell epitopes) could induce tolerance to egg allergens which represent an attractive solution to prevent and treat egg allergy. This could result in specific T-cell tolerance or anergy against the antigens. Modification of allergens will be performed by two different approaches, 1) recombinant hybrid peptides comprising OA or OVM MHC class II-restricted T-cell epitopes with E. coli expression system, and 2) site-directed mutagenesis altering dominant B-cell epitope structure or tertiary structure of the proteins. Hypo-sensitization and therapeutic tolerance of egg allergy will be evaluated using experimentally-induced allergy mice (BALB/c) by means of intraperitoneal of antigens. Analysis of Th1/Th2 and T-regulatory cells-associated cytokines (IFN-gamma, IL-4, IL-10, IL-12 and TGF-beta), specific antibodies (IgE, IgG1, IgG2a and IgG4) and histamine levels will be analyzed by enzyme-linked immunosorbent assay (ELISA) (splenocytes and sera) or real-time RT-PCR technique (mucosal immunity). The significance of the proposed project are 1) to direct us to develop hypo-food allergens or peptide-based immunotherapy for food allergic diseases, 2) better understanding mechanism of recombinant hypoallergen-induced immunotorelance, 3) to facilitate training of highly qualified personnel in food biotechnology/immunology/food safety area.